Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : PYNG Technologies -- Ignore unavailable to you. Want to Upgrade?

To: Wallof Confusion who wrote (463)	2/2/1998 9:26:00 PM
From: sPD	Read Replies (1) \| Respond to of 8117

The complete news release. FEBRUARY 2, 1998 Pyng Medical Receives Ethical Approval for F.A.S.T 1 System VANCOUVER, BRITISH COLUMBIA--Pyng Technologies Corp. is very proud to announce that subsidiary Pyng Medical Corp has received Ethical Approval for the F.A.S.T 1 (TM) System for Intraosseous Infusion from the University of Maryland Medical Center. Ethical Approval was required in order to proceed with full field trial evaluation of the F.A.S.T 1 Intraosseous Infusion System in live patients, in actual emergency room and pre-hospital conditions. The University of Maryland Medical Center (UMMC), one of America's major trauma centers, has agreed to conduct field trials and be the central data collection center for the F.A.S.T 1 (TM) System in the USA. Pyng Medical Corp is now cleared to proceed with UMMC on live trials at Maryland as well as many other sites selected for field trials in the USA and coordinated by UMMC. This news release follows our recently announced approval from the Ehtical Review Board of the University of British Columbia, Canada, to conduct field trials on the F.A.S.T 1 system at St. Paul's Hospital in Vancouver and Royal Columbian Hospital in New Westminster. Pyng Medical Corp. has consistently met the stringent requirements of both regulatory and ethical approvals necessary to take this life saving medical device to market. Pyng Medical's Corp.'s dedicated team is preparing to deliver out the F.A.S.T 1 System and the training tools as quickly as site visits can be arranged. Over the last few months Pyng Medical Corp. has achieved, - Canadian Health Protection Branch approval - U.S. FDA clearance #K970380 - 24 locations in America, including UMMC, selected for field trials subject to Ethical Approval (Cleared). - Canadian Hospitals selected for field trials subject to Ethical Approval (Cleared) - Grant for $100,000.00 from the B.C. Science Council for field trials. - Full presentation to the US Military at the Special Operations Medical Association. - F.A.S.T 1 System featured article in January 1998 issue of Journal of Emergency Medicine. disclaimer FOR FURTHER INFORMATION PLEASE CONTACT: Pyng Technologies Corp. Michael W. Jacobs President (604) 875-4526 (604) 875-5390 (FAX) Web Site: www.pyng.com The VSE has neither approved or reviewed the contents of this news release. NEWS RELEASE TRANSMITTED BY CANADIAN CORPORATE NEWS FOR: PYNG TECHNOLOGIES CORP. VSE SYMBOL: PYT